Global Artificial Intelligence in Diabetes Management Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers

1 Dec, 2023

The global artificial intelligence (AI) in diabetes management market is expected to grow from $0.36 billion in 2022 to $0.48 billion in 2023 at a compound annual growth rate (CAGR) of 31.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The artificial intelligence (AI) in diabetes management market is expected to reach $1.42 billion in 2027, at a CAGR of 31.4%.

Global Artificial Intelligence in Diabetes Management Market Key Driver

The rising prevalence of diabetes is expected to propel the artificial intelligence in the diabetes management market in the future. Diabetes, characterized by elevated blood glucose levels, leads to various complications such as eye problems, heart attacks, strokes, and kidney problems. Artificial intelligence plays a crucial role in managing diabetes by providing information about blood sugar levels, collecting previously unused data, and contributing to more effective diabetes management strategies.

Get a sample of the global artificial intelligence in diabetes management market report

Global Artificial Intelligence in Diabetes Management Market Segments

The global artificial intelligence in diabetes management market is segmented:
1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices

2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis

3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes

4) By Geography: The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global artificial intelligence in diabetes management market.

Major Artificial Intelligence in Diabetes Management Industry Players

  • Alphabet Inc.
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Medtronic Plc
  • Dexcom Inc.
  • Insulet Corporation
  • Tandem Diabetes Care Inc.
  • LifePlus Inc.
  • Livongo Health Inc.
  • Xeris Pharmaceuticals Inc.
  • Get the full global artificial intelligence in diabetes management market report

    Artificial Intelligence in Diabetes Management Market Overview

    Artificial intelligence in diabetes management refers to using AI technologies and algorithms to spot patterns in behavior that lead to either high or low blood sugar levels in diabetes patients. Artificial intelligence in diabetes management improves various aspects of diabetes care, including decision support, prediction, lifestyle guidance, and treatment management.

    Artificial Intelligence in Diabetes Management Global Market Report 2023 provides data on the global artificial intelligence in diabetes management market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The artificial intelligence in diabetes management market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.